CN103336134A - 一种检测her2和muc4蛋白表达的方法及其在癌症治疗中的应用 - Google Patents
一种检测her2和muc4蛋白表达的方法及其在癌症治疗中的应用 Download PDFInfo
- Publication number
- CN103336134A CN103336134A CN2013102858262A CN201310285826A CN103336134A CN 103336134 A CN103336134 A CN 103336134A CN 2013102858262 A CN2013102858262 A CN 2013102858262A CN 201310285826 A CN201310285826 A CN 201310285826A CN 103336134 A CN103336134 A CN 103336134A
- Authority
- CN
- China
- Prior art keywords
- section
- 5min
- immersion
- her2
- pbs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310285826.2A CN103336134B (zh) | 2013-07-09 | 2013-07-09 | 一种检测her2和muc4蛋白表达的方法及其在癌症治疗中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310285826.2A CN103336134B (zh) | 2013-07-09 | 2013-07-09 | 一种检测her2和muc4蛋白表达的方法及其在癌症治疗中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103336134A true CN103336134A (zh) | 2013-10-02 |
CN103336134B CN103336134B (zh) | 2016-03-23 |
Family
ID=49244337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310285826.2A Expired - Fee Related CN103336134B (zh) | 2013-07-09 | 2013-07-09 | 一种检测her2和muc4蛋白表达的方法及其在癌症治疗中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103336134B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104195230A (zh) * | 2014-07-24 | 2014-12-10 | 益善生物技术股份有限公司 | 曲妥珠单抗疗效相关基因表达检测液相芯片试剂盒 |
CN105699156A (zh) * | 2016-02-24 | 2016-06-22 | 福州迈新生物技术开发有限公司 | 一种用于载玻片上组织样品染色的全自动染色仪及使用方法 |
CN111551720A (zh) * | 2020-04-30 | 2020-08-18 | 昆山德诺瑞尔生物科技有限公司 | 一种检测ogn蛋白表达的方法及其在胃癌辅助诊断中的应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101726602A (zh) * | 2009-12-11 | 2010-06-09 | 南开大学 | 一种检测Legumain蛋白判断卵巢癌预后的方法 |
WO2012170470A1 (en) * | 2011-06-06 | 2012-12-13 | Board Of Regents Of The University Of Nebraska | Compositions and methods for detection and treatment of cancer |
-
2013
- 2013-07-09 CN CN201310285826.2A patent/CN103336134B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101726602A (zh) * | 2009-12-11 | 2010-06-09 | 南开大学 | 一种检测Legumain蛋白判断卵巢癌预后的方法 |
WO2012170470A1 (en) * | 2011-06-06 | 2012-12-13 | Board Of Regents Of The University Of Nebraska | Compositions and methods for detection and treatment of cancer |
Non-Patent Citations (6)
Title |
---|
PAULA R. POHLMANN ET AL: "Resistance to Trastuzumab in Breast Cancer", 《CLINNICAL CANCER RESEARCH》 * |
PETER NAGY ET AL: "Decreased Accessibility and Lack of Activation of ErbB2 in JIMT-1, a Herceptin-Resistant, MUC4-Expressing Breast Cancer Cell Line", 《CANCER RESEARCH》 * |
RITA NAHTA ET AL: "Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer", 《NATURE CLINICAL PRACTICE ONCOLOGY 》 * |
孙泽辉 等: "ADAM17与HER-2在乳腺癌中表达的意义及相关性", 《广东医学》 * |
李德本: "免疫组化染色的操作技巧和注意事项", 《临床与实验病理学杂志》 * |
顾芳英: "新辅助化疗前后不同亚型乳腺癌Ki-67的表达及意义", 《中国优秀硕士学位论文全文数据库( 医药卫生科技辑)》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104195230A (zh) * | 2014-07-24 | 2014-12-10 | 益善生物技术股份有限公司 | 曲妥珠单抗疗效相关基因表达检测液相芯片试剂盒 |
CN104195230B (zh) * | 2014-07-24 | 2016-09-07 | 益善生物技术股份有限公司 | 曲妥珠单抗疗效相关基因表达检测液相芯片试剂盒 |
CN105699156A (zh) * | 2016-02-24 | 2016-06-22 | 福州迈新生物技术开发有限公司 | 一种用于载玻片上组织样品染色的全自动染色仪及使用方法 |
CN111551720A (zh) * | 2020-04-30 | 2020-08-18 | 昆山德诺瑞尔生物科技有限公司 | 一种检测ogn蛋白表达的方法及其在胃癌辅助诊断中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103336134B (zh) | 2016-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chand et al. | Evaluation of immunohistochemical profile of breast cancer for prognostics and therapeutic use | |
Zhou et al. | Crosstalk between estrogen receptor and mitogen-activated protein kinase signaling in the development and progression of endometrial cancer | |
Singsuksawat et al. | Increased ETV4 expression correlates with estrogen-enhanced proliferation and invasiveness of cholangiocarcinoma cells | |
Guo et al. | Clinical significance of the correlation between PLCE 1 and PRKCA in esophageal inflammation and esophageal carcinoma | |
CN104808004B (zh) | Metrnl蛋白作为结肠癌诊断标志物的应用及试剂盒 | |
CN103336134A (zh) | 一种检测her2和muc4蛋白表达的方法及其在癌症治疗中的应用 | |
CN107576798A (zh) | Vdac1蛋白在制备乳腺癌术后预后评估试剂盒中的应用、乳腺癌预后评估试剂盒及方法 | |
CN103361430B (zh) | 一种检测pten基因和pi3k/akt蛋白的方法及其在癌症治疗中的应用 | |
CN106290895A (zh) | Chka蛋白在制备肝癌预后评估试剂盒中的应用、试剂盒及方法 | |
Jiang et al. | Ruyiping formula inhibits metastasis via the microRNA-134-SLUG axis in breast cancer | |
CN106370852B (zh) | 胃腺癌标志物Drosha蛋白及其应用 | |
Seifi et al. | Lack of elevated HER2/neu expression in epithelial dysplasia and oral squamous cell carcinoma in Iran | |
Cohen et al. | Immunohistochemical examinations of sex hormone receptors in benign vocal fold lesions | |
CN105112524A (zh) | 基于cdc27基因用于结直肠癌辅助诊断和/或预后判断的试剂盒 | |
CN103543266A (zh) | 检测pgrmc1的试剂在制备肾癌诊断试剂、试剂盒中的用途 | |
CN108273049A (zh) | Ddx3用于制备宫颈癌治疗药物的用途 | |
CN114231623B (zh) | Palmdelphin在制备人结直肠癌检测及治疗产品中的应用 | |
Lv et al. | Ruscogenin attenuated tight junction injury and tumor migration in colorectal liver metastasis mice via regulating TRAP1 | |
CN117643592B (zh) | 人参皂苷20(R)-25-OH-Rg2促进卵巢修复的用途 | |
CN102297971A (zh) | 一种检测癌或恶性肿瘤组织中jwa表达的试剂盒 | |
CN106645722B (zh) | 一种肺癌筛查试剂盒 | |
Beniuk et al. | Identifying the predictors of recurrence of endometrium polyps in women of reproductive age | |
CN106645723A (zh) | Shp2蛋白在制备肝癌对索拉菲尼疗效评估试剂盒中的应用 | |
CN107385100A (zh) | Mcm8作为胃腺癌转移标志物的用途 | |
Yahya et al. | Use of immunohistochemistry and silver in situ hybridization (SISH) in evaluation of human epidermal growth factor receptor2 (HER2/neu) status in Iraqi patients with breast cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Jia Hao Inventor after: Cong Qian Inventor after: Lu Zhiyue Inventor after: Guo Han Inventor after: Zhu Kai Inventor after: Liao Bo Inventor before: Jia Hao Inventor before: Cong Qian Inventor before: Guo Han Inventor before: Jiang Lina Inventor before: Lu Zhiyue |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: JIA HAO CONG QIAN GUO HAN JIANG LINA LU ZHIYUE TO: JIA HAO CONG QIAN LU ZHIYUE GUO HAN ZHU KAI LIAO BO |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160323 Termination date: 20200709 |
|
CF01 | Termination of patent right due to non-payment of annual fee |